Effects of γ-Aminobutyric Acid on the Erectogenic Properties of Sildenafil
Authors/Creators
- 1. Functional food and Nutraceutical Laboratory, Department of Biochemistry, Federal University of Technology, Akure, P.M.B. 704, Akure 340001, Nigeria
- 2. Department of Biomedical Technology, Federal University of Technology, Akure, P.M.B. 704, Akure 340001, Nigeria
Description
Erectile dysfunction (ED) is a disorder of increasing socio-economic burden. Therapeutic drugs such as sildenafil have been in use for the treatment of ED, but with their associated side effects. γ-aminobutyric acid (GABA) is a neurotransmitter with possible vasodilatory properties. In this study, the effect of GABA on the erectogenic properties of sildenafil was investigated. Aqueous solution of GABA and sildenafil (1 mM) was separately prepared as well as the mixtures of both (75% GABA + 25% sildenafil; 50% GABA + 50% sildenafil; 25% GABA + 75% sildenafil). Thereafter, the in vitro effects of all the studied samples on the activities of arginase, angiotensin-I converting enzyme (ACE) and acetylcholinesterase (AChE) were investigated. The results revealed that all the samples inhibited arginase, ACE and AChE activities. Considering the various combinations, 25% GABA + 75% sildenafil had the highest arginase inhibitory effect, 50% GABA + 50% sildenafil showed the highest ACE inhibiting effect, while 25% GABA + 75% sildenafil exhibited the highest AChE inhibitory effect. Therefore, the observed enzyme inhibiting effect of sildenafil, GABA and their various combinations on rat penile arginase, ACE and AChE activities could be part of the mechanism by which they elicit their erectogenic properties. The various combinations could thus serve as therapeutic intervention for the management of ED with a possible reduction in the side effects associated with the use of sildenafil; nevertheless, the combination of 75% GABA with 25% sildenafil exhibited the highest erectogenic potential.
Abstract (English)
Erectile dysfunction (ED) is a disorder of increasing socio-economic burden. Therapeutic drugs such as sildenafil have been in use for the treatment of ED, but with their associated side effects. γ-aminobutyric acid (GABA) is a neurotransmitter with possible vasodilatory properties. In this study, the effect of GABA on the erectogenic properties of sildenafil was investigated. Aqueous solution of GABA and sildenafil (1 mM) was separately prepared as well as the mixtures of both (75% GABA + 25% sildenafil; 50% GABA + 50% sildenafil; 25% GABA + 75% sildenafil). Thereafter, the in vitro effects of all the studied samples on the activities of arginase, angiotensin-I converting enzyme (ACE) and acetylcholinesterase (AChE) were investigated. The results revealed that all the samples inhibited arginase, ACE and AChE activities. Considering the various combinations, 25% GABA + 75% sildenafil had the highest arginase inhibitory effect, 50% GABA + 50% sildenafil showed the highest ACE inhibiting effect, while 25% GABA + 75% sildenafil exhibited the highest AChE inhibitory effect. Therefore, the observed enzyme inhibiting effect of sildenafil, GABA and their various combinations on rat penile arginase, ACE and AChE activities could be part of the mechanism by which they elicit their erectogenic properties. The various combinations could thus serve as therapeutic intervention for the management of ED with a possible reduction in the side effects associated with the use of sildenafil; nevertheless, the combination of 75% GABA with 25% sildenafil exhibited the highest erectogenic potential.
Files
IJTPR,Vol9,Issue3,Article10.pdf
Files
(579.2 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:1df89b1ad1a58758bf003a6ec47e5e05
|
579.2 kB | Preview Download |
Additional details
Dates
- Accepted
-
2017-07-25
Software
References
- 1. Bella A, Lue T. Male sexual dysfunction. In: Tanagho E, editors. Smith's General Urology, 17th edd; pp. 589-610. New York: Lange/McGraw Hill, 2008. 2. NIH. NIH consensus conference: impotence. (JAMA) The Journal of American Medicine Association 1993; 270: 83–90. 3. Green JS, Holden ST, Ingram P, Bose P, St-George DP Bowsher WG. An investigation of erectile dysfunction in Gwent, Wales. British Journal Urology International 2001; 88: 551–53. 4. Förstermann U, William CS. Nitric oxide synthases: regulation and function. European Heart Journal 2012; 33(7): 829-837. 5. Cox JD, Kim NN, Traish AM, Christianson DW. Arginase-boronic acid complex highlights a physiological role in erectile function. Nature Structural Biology 1999; 6: 1043–1047. 6. Butterfield DA, Lauderback CM. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radical Biology and Medicine, 2002; 32: 1050– 1060. 7. Ballard CG, Greig NH, Guillozet-Bongaarts AL, Enz A, Darvesh S. Cholinesterases: Roles in the brain during health and disease. Current Alzheimer Research 2005; 2: 307–318. 8. Sung BJ, Hwang K, Jeon Y, Lee JI, Heo YS, Kim J, Moon J, Yoon J, Hyun YL, Kim E, Eum S, Park SY, Lee JO, Lee T, Ro S, Cho J. Structure of the catalytic domain of human phosphodiesterase-5 with bound drug molecules. Nature 2003; 425: 98–102. 9. Webb DJ, Freestone S, Allen MJ, Muirhead GJ. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist. American Journal of Cardiology 1999; 83: 21–28. 10.Steward FC, Thompson JF, Dent CE. γ-Aminobutyric acid: a constituent of the potato tuber. Science 1949; 110(2861): 439-440. 11.Bouche N, Fromm H. GABA in plants: just a metabolite?. Trends in plant science 2004; 9(3); 110- 115. 12.Park DH, Mirabella R, Bronstein PA, Preston GM, Haring MA, Lim CK, Collmer A, Schuurink RC. Mutations in γ-aminobutyric acid (GABA) transaminase genes in plants or Pseudomonas syringae reduce bacterial virulence. Plant Journal 2010; 64(2): 318–330. 13.Chapman RW, Hey JA, Rizzo CA, Bolser DC. GABA-B receptors in the lung. Trends in Pharmacological Sciences 1993;14(1): 26-29. 14.He XB, Hu JH, Wu Q, Yan YC, Koide SS. Identification of GABA-B receptor in rat testis and sperm. Biochemical and Biophysical Research Communications 2001; 283(1): 243-247. 15.Watanabe M, Maemura K, Kanbara K, Tamayama T, Hayasaki H. GABA and GABA receptors in the central nervous system and other organs. International Review of cytology 2002; 213: 1-47. 16.Nappi RE Albani F, Valentino V. Aging and sexuality in women. Minerva Ginecologica 2007; 59: 287-98. 17.Pinna G, Agis-Balboa RC, Pibiri F. Neurosteroid biosynthesis regulates sexually dimorphic fear and aggressive behaviour in Mice. Neurochemical Research 2008; 33: 1990-2007. 18.Lovinger DM. Serotonin's role in alcohol's effects on the brain. Alcohol Research and Health 1997; 21(2): 114. 19.Andersson KE. Neurotransmitters: central and peripheral mechanisms. International Journal of Impotence Research 2000; 4: 26-33. 20.Kaysen GA, Strecker HJ. Purification and properties of arginase of rat kidney. Biochemical Journal 1973; 133: 779–788. 21.Cushman DW, Cheung HS. Spectrophotometric assay and properties of the Angiotensin I-converting enzyme of rabbit lung. Biochemical Pharmacology 1971; 20: 1667-1648. 22.Oboh G, Odubanjo VO, Bello F, Ademosun AO, Oyeleye SI, Nwanna EE, Ademiluyi AO. Aqueous extracts of avocado pear (Persea americana Mill.) leaves and seeds exhibit anti-cholinesterases and antioxidant activities in vitro. Journal of Basic and Clinical Physiology and Pharmacology 2016; 27: 131- 140. 23.Ademosun AO, Oboh G, Olupona AJ, Oyeleye SI, Adewuni TM, Nwanna EE. Comparative study of chemical composition, in vitro inhibition of cholinergic and monoaminergic enzymes, and antioxidant potentials of essential oil from peels and seeds of sweet orange (Citrus Sinensis [L.] Osbeck) Fruits. Journal of Food Biochemistry 2016; 40(1): 53- 60.. 24.Adefegha SA, Oboh G, Oyeleye SI, Dada FA, Ejakpovi I, Boligon AA. Cognitive enhancing and antioxidative potentials of velvet beans (Mucuna pruriens) and Horseradish (Moringa oleifera) seed extracts: A comparative study. Journal of Food Biochemistry 2016; DOI: 10.1111/jfbc.12292 25.Akomolafe SF, Oboh G, Oyeleye SI, Boligon AA. Aqueous extract from Ficus capensis leaves inhibits key enzymes linked to erectile dysfunction and prevent oxidative stress in rats' penile tissue. NFS Journal, 2016; 4: 15-21. 26.Burnett AL, Lowenstein CJ, Bredt DS, Chang TS, Snyder SH. Nitric oxide: a physiologic mediator of penile erection. Science 1992; 257: 401–403. 27.Bivalacqua TJ, Champion HC, Hellstrom WJ, Kadowitz PJ. Pharmacotherapy for erectile dysfunction. Trends in Pharmacological Sciences 2000; 21: 484-489. 28.Kim NN, Cox JD, Baggio RF, Emig FA, Mistry SK, Harper SL, Speicher DW, Morris SM, Ash DE, Traish A, Christianson DW. Probing erectile function: S-(2- boronoethyl)-L-cysteine binds to arginase as a transition state analogue and enhances smooth muscle relaxation in human penile corpus cavernosum. Biochemistry, 2001; 40(9): 2678-2688. 29.Watts GF, Chew KK, Stuckey BG. The erectileendothelial dysfunction nexus: new opportunities for cardiovascular risk prevention. Nature Clinical Practice Cardiovascular Medicine 2007; 4: 263-273. 30.Becker AJ, Uckert S, Stief CG. Possible role of bradykinin and angiotensin II in the regulation of penile erection and detumescence. Urology 2001; 57: 193-198. 31.Ferrario CM, Levy P. Sexual dysfunction in patients with hypertension: implications for therapy. Journal of Clinical Hypertension 2002; 4: 424-432. 32.Hale TM, Okabe H, Heaton JPW, Adams MA. Antihypertensive drugs induce structural remodelling of the penile vasculature. The Journal of Urology 2001; 166: 739-745. 33.Douma S, Doumas M, Tsakiris A, Zamboulis C. Male and female sexual dysfunction: is hypertension an innocent bystander or a major contributor. Rev Bras Hypertens 2007; 14: 139-147. 34.Andersson KE, Wagner G. Physiology of penile erection. Physiological Review 1995; 75: 191-236. 35.Hedlund P, Alm P, Andersson KE. NO synthase in cholinergic nerves and NO-induced relaxation in the rat isolated corpus cavernosum. British Journal of pharmacology 1999; 127: 349–360. 36.Hedlund P, Ny L, Alm P, Andersson KE. Cholinergic nerves in human corpus cavernosum and spongiosum contain nitric oxide synthase and heme oxygenase. The Journal of Urololgy 2000; 164: 868–875. 37.Ayajiki K, Hayashida H, Tawa M, Okamura T, Toda N. Characterization of nitrergic function in monkey penile erection in vivo and in vitro. Hypertension Research 2009; 32: 685–689. 38.Hull EM, Pehek EA, Bitran, D, Holmes GM, Warner RKB d L. C., Bazzett, T. Clemens LG. Brain localization of cholinergic influence on male sex behaviour in rats: antagonists. Pharmacology, Biochemistry and Behavior 1988a; 31: 175–178. 39.Hull EM, Bitran D, Pehek EA, Holmes GM, Warner RK, Band LC, Clemens LG. Brain localization of cholinergic influence on male sex behavior in rats: agonists. Pharmacology Biochemistry and Behavior 1988b; 31: 169–174. 40.Maeda N, Matsuoka N, Yamaguchi I. Septohippocampal cholinergic pathway and penile erections induced by dopaminergic and cholinergic stimulants. Brain Reserch 1990; 537: 163–168. 41.Maeda N, Matsuoka N, Yamaguchi I. Role of the dopaminergic, serotonergic and cholinergic link in the expression of penile erection in rats. The Japanese Journal of Pharmacology 1994; 66: 59–66. 42.Adefegha SA, Oboh G. Inhibition of key enzymes linked to type-2 diabetes and sodium nitroprussideinduced lipid peroxidation in rat pancreas by water extractable phytochemicals from some tropical spices. Pharmaceutical. Biology 2012; 50: 857 – 865. 43.Adefegha SA, Oboh G, Oyeleye SI, Ejakpovi II. Erectogenic, antihypertensive, antidiabetic, anti- oxidative properties and phenolic compositions of Almond fruit (Terminalia catappa L.) parts (hull and drupe) – in vitro. Journal of Food Biochem 2016; Doi: 10.1111/jfbc.12309 44.Oboh G, Puntel RL, Rocha JBT. Hot pepper (Capsicum anuum, Tepin and Capsicum chinese, Habanero) prevents Fe2+-induced lipid peroxidation in brain-in vitro. Food Chemitry 2007; 102: 178-85.